RYAN SHOLINSKY: Open Payments
NPI 1922544923 · WILLOW GROVE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 19 payments from 11 companies in 2025. Trend: 2023 $109 · 2024 $451 · 2025 $601
Food & beverage: $601
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 5 | $171 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $117 |
| ViiV Healthcare Company | 3 | $87 |
| ABBVIE INC. | 2 | $39 |
| Indivior Inc. | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| Cepheid | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| Theratechnologies Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
Products named: BRIXADI, Kerendia, APRETUDE, MAVYRET, SUBLOCADE, INGREZZA, GeneXpert, PIFELTRO.
Industry payments across PA — which companies pay providers there.
